Non-Invasive Prenatal Diagnosis (NIPD) is a DNA test on maternal blood to diagnose prenatally a limited number of monogenic disorders in the fetus:
- Cystic fibrosis
- Achondroplasia and thanatophoric dysplasia due to specific FGFR3 mutations
- Craniosynostosis due to specific FGFR2 mutations
- Apert syndrome
- Crouzon syndrome with acanthosis nigricans
More details on NIPD tests can be found in the different NIPD brochures.
10 ml blood in specific blood tubes provided by GENDIA is required from the mother.